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One sentence summary: Chlamydia trachomatis DNA is present in intestinal biopsy samples of patients and might travel from the oral to the rectal site.
Editor: Peter Timms
ABSTRACT
Chlamydia trachomatis is frequently detected in anorectal specimens from men and women. A recent hypothesis suggests
that C. trachomatis is a natural commensal organism asymptomatically colonizing the gastrointestinal tract. In this study,
we investigated the presence of chlamydial DNA and antigen in intestinal biopsy samples taken during colonoscopy. Cases
(n = 32) were patients whose histopathology reports included the term ‘chlamydia’, suggesting a possible history of
infection. Control patients (n = 234) did not have chlamydia mentioned in their histopathology report and all tested
negative for Chlamydiaceae DNA by 23S ribosomal RNA-based real-time PCR. Amongst the cases, C. trachomatis DNA was
detected in the appendix and colon of two female and one male patients. Chlamydia abortus DNA was present in the colon of
a fourth female patient. Thus, chlamydial DNA could be demonstrated in intestinal biopsy samples proximal to the
anorectal site and inclusions were identified in rectum or appendix of two of these patients by immunohistochemistry.
However, the findings in two cases were compatible with sexually acquired C. trachomatis. The identification of C. trachomatis
DNA/antigen does not prove the presence of active infection with replicating bacteria. Larger prospective studies on fresh
tissue samples are required to confirm the data obtained in this study.
Keywords: Chlamydia trachomatis; rectal infection; colonoscopy; formalin-fixed and paraffin-embedded; biopsy specimens;
gastrointestinal tract; reservoir
INTRODUCTION
Chlamydia trachomatis is the most commonly reported bacte-
rial sexually transmitted infection (STI) worldwide, with an
estimated 131 million new cases in 2012 (Newman et al.
2015). Chlamydia trachomatis serovars D-K and L1-L3 primarily
cause non-invasive genitourinary infections and invasive lym-
phogranuloma venereum, respectively. Genital C. trachomatis in-
fection is foundmost often in 15 to 24-year-old women and 20 to
29-year-oldmen.Manypatients are asymptomatic (women 70%–
90%, men 30%–50%), thusmost cases likely remain undiagnosed
and unreported (Markle, Conti and Kad 2013). Factors, other than
age, that have been associated with genital chlamydial infection
include multiple sex partners, intermittent condom use, cervi-
cal ectopy, history of other STIs, and low educational status or
socioeconomic position (Markle, Conti and Kad 2013; reviewed
by Leonard and Borel 2014).
The role and pathogenicity of C. trachomatis in the human
gastrointestinal (GI) tract are increasingly debated because of
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proposals to test and treat more women and men who have sex
with men (MSM) for C. trachomatis detected in anorectal swabs
using nucleic acid amplification tests (NAATs) (Dukers-Muijrers
et al. 2015). Genitourinary C. trachomatis primarily infects colum-
nar mucosal epithelial cells in the endocervix in women, the
urethra in women and men. It can also infect rectal colum-
nar epithelium in both women and men. A systematic review
found that almost 70% ofwomenwith genitourinary C. trachoma-
tis infection were also positive for rectal C. trachomatis by NAAT,
but reported anal intercourse was not associated with detec-
tion of anorectal C. trachomatis (Chandra et al. 2018). Positive
NAAT results for anorectal C. trachomatis could reflect the detec-
tion of non-viable chlamydial nucleic acid, rather than infection.
The finding is also consistent with the hypothesis that auto-
inoculation, transferring C. trachomatis between the genital and
anorectal mucosa, can maintain infection in women in the ab-
sence of direct inoculation through anal intercourse (Rank and
Yeruva 2014). Schachter et al. (1979, 1986) reported the presence
of viable chlamydiae at different anatomical sites in a prospec-
tive study of 131 infants born to C. trachomatis-infected mothers.
Chlamydiae were recovered by culture from the conjunctiva and
nasopharynx within the first 3 weeks of life. Unexpectedly, sev-
eral infants who had been previously repeatedly tested negative
at the rectum became positive after 3–5 months after birth, sug-
gesting that indirect routes of inoculation are possible.
Bavoil and colleagues have proposed that, as in animals, C.
trachomatis is a natural commensal organism in the human GI
tract, asymptomatically colonizing one or more sites (Bavoil
et al. 2017). Chlamydia muridarum infection studies in mice
indicate that the GI tract, an immunologically protected site,
may be a reservoir for genital re-infection (Perry and Hughes
1999; Igietseme, Portis and Perry 2001; Rank and Yeruva 2014),
and long-term chlamydial colonization of the murine GI tract
has been demonstrated (Yeruva et al. 2013b; Zhang et al. 2015).
Moreover, eradication of chlamydial infection by azithromycin
treatment in mice was less effective for GI than for genital
infection (Yeruva et al. 2013a).
Although anorectal C. trachomatis is commonly diagnosed by
NAATs in women and MSM (Van Liere et al. 2014, 2015; Dukers-
Muijrers et al. 2015; Chandra et al. 2018), the presence of C. tra-
chomatis DNA and/or antigen at more proximal GI sites such as
ileum, cecum, appendix and colon have yet to be investigated.
The objectives of this study were to examine intestinal biopsy
samples taken during colonoscopy for the presence of chlamy-
dial DNA and antigen in patients with and without a history of
chlamydial infection and to examine factors associated with a
history of chlamydial infection.
MATERIALS AND METHODS
We conducted this study using pathology records and
histopathological specimens obtained during colonoscopy
from patients with and without documentation of a history of
chlamydial infection.
Definitions of cases and controls
We defined a case as a patient with a possible history of chlamy-
dial infection investigated by colonoscopy at the cantonal hospi-
tal Winterthur. We searched for the term ‘chlamydia’ anywhere
in the clinical history or in the comments section of histopathol-
ogy reports, which are stored electronically. The time period an-
alyzed ranged from 1999 to 2013. If a patient had more than one
colonoscopy, we used the findings from only one examination.
We chose only episodes in which the keyword ‘chlamydia’ ap-
peared in the histopathology report and if it appearedmore than
once, we used the most recent information.
The control group consisted of 234 randomly but chronolog-
ically (according to numbers of pathology reports) selected pa-
tients at the cantonal hospitalWinterthurwhose histopathology
record did not contain the word ‘chlamydia’. All these patients
underwent colonoscopy in 2013.
We extracted the same information from the records of
both cases and controls and coded each variable, as follows:
group assignment (case or control), sex (female or male),
clinical signs (none or any, such as abdominal pain, diar-
rhea etc.), biopsy site (ileum, colon, cecum, appendix, rectum)
and results of NAATs done as part of this study to detect
chlamydial species (positive or negative). Two pathologists re-
viewed all histopathology reports and categorized diagnoses
as the following: no abnormality, polyp(s), neoplasia, infec-
tion/inflammation, ischemia/fibrosis, infection/inflammation
ANDpolyp(s)/neoplasia. All polypswere of the hyperplastic type.
Neoplasia included benign epithelial (adenoma) and malignant
epithelial tumors (carcinoma). Information about prior or cur-
rent antibiotic treatment was not available from the patient
records.
Intestinal biopsy specimens
Formalin-fixed and paraffin-embedded (FFPE) tissue blocks from
each patient were retrieved from the pathology archive of the
cantonal hospital Winterthur. FFPE blocks containing intestinal
anatomic localizations such as ileum, colon, cecum, appendix
and rectum were chosen for the study. FFPE blocks containing
biopsies taken from the esophagus, stomach and duodenum of
the same patients were excluded. Pathology reports of hema-
toxylin and eosin (HE)-stained sections from all patients were
retrieved from the database. The cantonal ethical committee of
Zurich approved this project with the limitation that only sam-
ples dated prior to December 2013 were allowed to be included.
Statistical analysis
All datawere entered in an Excel R© spreadsheet and analyzed us-
ing Stata (version 15, Stata Corporation, College Station, Texas).
We used descriptive statistics to compare demographic, clinical
and histopathological characteristics of cases with a history of
chlamydia and control patients. Because of the small number
of biopsies for some anatomic sites, we considered all biopsies
from each patient together and assigned a histopathological di-
agnosis for each patient. No patient had different abnormal find-
ings at more than one site. We calculated odds ratios (OR, with
95% confidence intervals, CI) to examine the strength of asso-
ciation with a history of chlamydia. Owing to small numbers of
observations for several strata, we did not conductmultivariable
analysis.
DNA extraction
From each FFPE block, one 20-μm section was cut and deparaf-
finized in xylene by centrifugation at 13 800× g for 5 min. The
supernatant containing the xylene was removed, and the sam-
ple washed twice in ethanol, centrifuged at 14 800× g for 5 min
followed by removal of the supernatant. The remaining pellet
was lysed with proteinase K (20 mg/ml, Roche Diagnostics,
Mannheim, Germany) on a thermomixer at 56◦C and 550 rpm
overnight. DNA was extracted using the commercial DNeasy
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Blood and Tissue Kit (Qiagen, Hilden, Germany) according to the
manufacturer’s instructions. All extracts were examined with
the Nanodrop R© 1000 Version 3.7.1 (Thermo Fisher Scientific,
Waltham, MA, USA) to determine DNA quantity and quality.
Real-time PCR for Chlamydiaceae
We examined all specimens for the presence of DNA by
real-time PCR. Extracted DNA was analyzed on an Applied
Biosystems 7500 Real-Time PCR System (Thermo Fisher Sci-
entific) based on the 23S rRNA gene Chlamydiaceae family-
specific real-time PCR as described by Ehricht et al. (2006),
with primers Ch23SF (5′CTGAAACCAGTAGCTTATAAGCGGT3′),
Ch23SR (5′ACCTCGCCGTTTAACTTAACTCC3′) and probe Ch23Sp
(5′FAMCTCATCATGCAAAAGGCACGCCGTAMRA3′), modified ac-
cording to Blumer et al. (2011) to include an internal positive con-
trol (enhanced green fluorescent protein, eGFP) (Hoffmann et al.
2006), with primers EGFP1F (5′GACCACTACCAGCAGAACAC3′),
EGFP10R (3′CTTGTACAGCTCGTCCATGC5′) and probe EGFP1HEX
(5′HEXAGCACCCAGTCCGCCCTGAGCABHQ13′). The protocol by
Blumer et al. (2011) was modified as follows: each 25 μl con-
tained 12.5 μl Applied Biosystems TaqMan Fast Universal PCR
MasterMix (2×) (Thermo Fisher Scientific), 500 nM of each
primer Ch23SF and Ch23SR, 200 nM of probe Ch23Sp, 100 nM
of each eGFP primer EGFP 1F and EGFP10R, 50 nM of eGFP probe
EGFP1HEX, 0.25 μl eGFP template and 2.5 μl sample template (all
primers and probes fromMicrosynth, Balgach, Switzerland). The
products of the Chlamydiaceae and egfp PCRs consist of ampli-
cons of 111 and 177 bp, respectively. The fast cycling profile of
the instrument was used: initial denaturation at 95◦C for 20 s,
followed by 45 cycles of denaturation/elongation (95◦C, 3 s and
60◦C, 30 s). All samples were tested in duplicate and the cycle
threshold was set at 0.1 for each run. Amean cycle threshold (Ct
value) <38 was considered positive, and was used to calculate
the corresponding chlamydial load as Chlamydiaceae 23S rRNA
gene copy number per μl (Staub et al. 2018). If several serial sec-
tions (see below) of the same FFPE block were positive, the sam-
plewith the lowest Ct valuewas used for the copy number calcu-
lation. If the amplification of internal control DNAwas inhibited,
the run was repeated following 1:10 dilution of the sample. A
positive control containing a sevenfold dilution series of C. abor-
tus DNA and a negative control of water instead of the template
DNA were included in each run (Hoffmann et al. 2015).
In PCR-positive cases after the initial screen, ten consecu-
tive sections from each FFPE block were prepared alternating
between repetition of the PCR analysis (n = 5) and chlamydial
antigen detection by immunohistochemistry (IHC; n = 5) as de-
scribed previously (Thierry et al. 2016).
Chlamydial species identification by Arraymate
Microarray
All samples positive by theChlamydiaceae real-time PCRwere fur-
ther investigated using a species-specific 23S rRNA gene Array-
mate microarray assay (Alere, Jena, Germany), as established by
Borel et al. (2008). The current version carries 34 probes for 11
Chlamydiaceae species, three genus-specific probes, four family
markers and 15 probes for Chlamydia-like organisms. Addition-
ally, there are four internal control DNA probes and an inter-
nal staining control (biotin marker) (Hoffmann et al. 2015). Each
sample, including internal control DNA (Intype IC-DNA, Qiagen
Labor, Leipzig, Germany), was amplified and biotin-labeled us-
ing a biotinylation PCR, as described by Borel et al. (2008), with
10 min of initialization (96◦C) and 40 cycles of 94◦C (denatura-
tion), 50◦C (annealing) and 72◦C (elongation) for 30 s each. Four
to 8 microliter of amplification product was loaded on the chip,
which was processed according to manufacturer’s instructions.
ompA PCR and sequencing
Samples identified as C. trachomatis by Arraymate Microar-
ray were further characterized by conducting a PCR target-
ing a 219-bp sequence of the variable domain VD-1 region of
the C. trachomatis ompA gene using the primer pair omp-V1-F
(5′-GACTTTGTTTTCGACCGTGTT-3′) and omp-V1-R (5′-ACAAA
TACATCAAACGATCCCA-3′) as previously described (Jalal et al.
2007; Kese et al. 2011) using FastStart Taq DNA polymerase
(Roche, Basel, Switzerland) under a temperature profile of 95◦C
for 5 min followed by 40 cycles of 95◦C for 60 s, 65◦C for 60 s and
72◦C for 90 s. Amplicons were purified with the QIAquick PCR
Purification Kit (Qiagen) and Sanger sequenced by Microsynth.
Chlamydial antigen detection by
immunohistochemistry
The presence of chlamydial antigen in paraffin sections was
examined on real-time PCR-positive cases using a Chlamydi-
aceae family-specific mouse monoclonal antibody targeting the
chlamydial lipopolysaccharide (LPS, Clone ACI-P, Progen, Hei-
delberg, Germany) (Blumer et al. 2011). A detection kit (Dako,
Santa Clara, CA, USA) was used according to the manufacturer’s
instructions. After deparaffinization in xylene and rehydration
through graded ethanol to water, the antigen retrieval was per-
formed by a 10-min enzyme digestion (Proteinase K, Dako).
The endogenous peroxidase activity was inhibited as described
above, then slides were incubated for 60 min with the primary
antibody diluted 1:200 in antibody diluent (Dako). The incuba-
tion with the link antibody and the substrate solution as well
as the counterstaining with hematoxylin was performed as de-
scribed above. For the positive control, intestinal tissue from
gnotobiotic piglets experimentally infectedwith porcineChlamy-
dia suis strain S45 was used (Guscetti et al. 2000).
RESULTS
We retrieved a total of 557 FFPE blocks from 266 patients.
The majority of the FFPE control group blocks contained colon
(n = 206) and, to a lesser extent, ileum (n = 99) and rectum
(n = 25). Cecum and appendix were only available in seven and
one patients, respectively. FFPE blocks of the case group con-
tained colon (n = 26), ileum (n = 19), rectum (n = 15), appendix
(n = 10) and cecum (n = 1). Patients in both groups underwent
colonoscopy because of a risk of colon cancer (e.g. family his-
tory), for check-ups (e.g. after surgery), or to investigate clinical
symptoms or signs (e.g. non-specific abdominal disorders, diar-
rhea etc.). Amongst 32 patients identified as cases, 27 underwent
colonoscopy once, and five had between two to five examina-
tions between 1999 and 2013. From 42 datasets of 32 patients,
we examined 91 FFPE samples. In the control group, all patients
(n = 234) underwent colonoscopy once in 2013. Compared with
the control group, biopsies for cases were more often available
from the appendix and rectum (Table 1).
Description of patients
Details of patient characteristics, presence of clinical signs and
histopathological diagnosis are shown in Table 1.
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Table 1. Description of data, according to study group.
Total Case Control
N = 266 N = 32 N = 234
Variable n (%)a n (%)a Odds ratio (95% CI) P value
Sex 0.243
Female 149 21 (65.6) 128 (54.7) 1
Male 117 11 (34.4) 106 (45.3) 0.63 (0.29, 1.38)
Age in years, mean (SD) 58.8 (16.9) 38.8 (22.3) 61.6 (14.0) <0.001
<60 years 120 26 (81.3) 94 (40.2) 6.45 (2.47, 16.90)
60+ years 146 6 (18.8) 140 (59.8) 1
Biopsy siteb,c
Ileum 115 16 (50.0) 99 (42.3) 1.36 (0.65, 2.86) 0.410
Colon 225 19 (59.4) 206 (88.0) 0.20 (0.09, 0.46) <0.001
Cecum 8 1 (3.1) 7 (3.0) 1.05 (0.12, 8.83) 0.828
Appendix 11 10 (31.3) 1 (0.4) 105.9 (9.25, >1000) <0.001
Rectum 40 15 (46.9) 25 (10.7) 7.38 (3.12, 17.4) <0.001
Histological diagnosis <0.001
Infection/inflammation 64 24 (75.0) 40 (17.1) 7.08 (2.49, 20.11)
Infection+polyps/hyperplasia 13 2 (6.3) 11 (4.7) 2.15 (0.37, 12.49)
Polyps/hyperplasia 35 0 (0.0) 35 (15.0) na
Neoplasia 85 0 (0.0) 85 (36.3) na
Ischemia/fibrosis 5 1 (3.1) 4 (1.7) 2.95 (0.27, 31.70)
No abnormality 64 5 (15.6) 59 (25.2) 1
Clinical signs <0.001
Yes 138 32 (100) 106 (45.3) na
No 128 0 (0.0) 128 (54.7) 1
Chlamydiaceae detected <0.001
Yes 4 4 (12.5) 0 (0.0) na
No 262 28 (87.5) 234 (100) 1
aNumbers presented are mean and standard deviation for age.
bTotal is greater than 276 because patients could have biopsy from more than one site.
cOdds ratio calculated separately for each site comparing cases and controls.
Abbreviations: na, not available (odds ratio could not be calculated because of zero count in one cell); SD, standard deviation.
There were more female patients amongst both cases (21/32)
and controls (128/234). The age range of both groupswas similar;
year of birth ranged from 1924 to 1990 amongst cases and from
1926 to 1984 for controls, but the mean age of cases was lower
than that of controls (38.8 versus 61.6 years).
Clinical symptoms or signs were present in all case pa-
tients (n = 32) and in 106 of 234 (45.3%) controls. The most fre-
quent histopathological diagnoses, retrieved from the archived
pathology reports, were infectious or inflammatory type lesions
amongst cases (n = 24) and neoplasia (n = 85) or no abnormal-
ity (n = 59) amongst controls. Infection/inflammation was more
common amongst cases than controls (OR 7.08, 95% CI 2.49–
12.49) (Table 1).
Detection of Chlamydia
The real-time PCR for Chlamydiaceaewas negative in all samples
(n = 464) from 234 control patients.
Real-time PCR for Chlamydiaceae was positive in four tissues
(appendix: n = 2; colon: n = 1; rectum: n = 1) from 4 of 32 (12.5%,
95% CI 3.5–29.0%) patients with a history of chlamydia (Table 2).
Of these, C. trachomatis was identified in three patients and C.
abortus in one patient by Arraymate microarray. Of the three
C. trachomatis-positive patients, two were female and one was
male.
The male C. trachomatis-positive patient (patient 2) was also
HIV-positive, and the clinical record included positive test re-
sults for C. trachomatis andNeisseria gonorrhoeae. The histopatho-
logic diagnosis was an ulcero-granulative colitis and active proc-
titis. From the tissues available (ileum, colon, rectum), only the
rectum was positive by PCR (48.2 copies per μl) and Arraymate
Microarray (positive for C. trachomatis). Sequencing of the PCR
product in the VD-I region of ompA revealed 99% homology to
the C. trachomatis LGV ompA-genotype L2. By IHC, three out of
five serial sections of the rectum contained one or two chlamy-
dial inclusions per section in the lamina propria (Fig. 1A). The
ileum and colon were negative for Chlamydiaceae antigen detec-
tion by IHC (Table 2).
The younger female patient (24 years, patient 4) had a
clinical history indicative of Chlamydia-associated adnexitis.
The histological examination of the appendix revealed an acute
partially fibrinous serositis. The appendix was positive for C.
trachomatis by Arraymate, and by IHC four out of five serial
sections contained 1 or 2 chlamydial inclusions in the lamina
propria (Fig. 1B). The copy number in the PCR-positive appendix
was 186.2 per μl and sequencing of the PCR product in the VD-I
region of ompA revealed 99% homology to the C. trachomatis
ompA-genotype F.
The older female patient (age 55 years, patient 1) suf-
fered from unclear abdominal pain in the lower right quad-
rant, which was the reason for undergoing diagnostic la-
paroscopy and appendectomy. Histological investigation of the
appendix revealed a mild, acute, granulocytic mucosal inflam-
mation and local serositis. The available PCR-positive tissue (ap-
pendix) was positive for C. trachomatis by Arraymate but nega-
tive by IHC. The copy number in the PCR-positive appendix was
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Table 2. Characteristics of patients with Chlamydiaceae detected.
Biopsy available, PCR result (copy number per μl)
Case Sex Age, yr Ileum Colon Cacum Appendix Rectum Arraymate result
Immunhisto-
chemistry
1 Female 55 No No No Yes, +ve (7.8) No C. trachomatis –ve
2 Male 40 Yes, –ve Yes, –ve No No Yes, +ve (48.2) C. trachomatis +ve, rectum
3 Female 81 Yes, –ve Yes, +ve (349.1) No No No C. abortus –ve
4 Female 24 No No No Yes, +ve (186.2) No C. trachomatis +ve, appendix
yr, years; –ve, negative; +ve, positive.
Figure 1. Immunohistochemistry using a Chlamydiaceae-family-specific mouse
monoclonal antibody targeting the chlamydial lipopolysaccharide (LPS, Clone
ACI-P, Progen), AEC/peroxidase method, hematoxylin counterstain. (A) Positive
immunolabeling of 2 chlamydial inclusions in the epithelium of the rectal mu-
cosa from patient 2 (magnification 400×). (B) Positive immunolabeling of a sin-
gle chlamydial inclusion in the appendix tissue from patient 4 (magnification
400×). Inset: granular appearance of the chlamydial inclusion in B (magnifica-
tion 1000×, oil immersion).
7.8 per μl and PCR targeting the VD-I region of ompA was not
successful.
The C. abortus-positive patient (female, age 81 years, patient
3) underwent four colonoscopic examinations between 2011
and 2013. The Chlamydia-positive PCR result (349.1 copies per
μl) was obtained from the colon sample in 2011. The clinical
history at that time included bleeding from the anus and colitis
ulcerosa as differential diagnosis. Histopathological examina-
tion revealed active colitis with cryptitis (inflammation of the
colonic crypts) but the colon was negative for Chlamydiaceae by
IHC. Follow-up examinations (n = 3) included the histopatho-
logical examination of the ileum and the colon which remained
negative for Chlamydia by PCR. Diagnoses were colitis and polyp
in 2012, ulcero-granulative colitis with epitheloid granulomas
in 2012 and chronic-active colitis with cryptitis in 2013.
DISCUSSION
Chlamydia trachomatis is frequently detected in anorectal speci-
mens from women and MSM. A recent hypothesis (Bavoil et al.
2017) proposes that chlamydiae, taken up during oral sex prac-
tices, survive in and colonize the GI tract, reaching the rectum.
Through fecal shedding, repeated contamination of the female
lower genital tract might take place, with a possibility of repro-
ductive sequelae in women if elementary bodies reach the en-
docervix (Bavoil et al. 2017). Intestinal colonization by chlamy-
diae in animal hosts, e.g. birds, pigs and ruminants, resulting
in fecal shedding with subsequent fecal-oral transmission, has
been well-documented for decades (Bavoil et al. 2017). However,
anorectal PCR positivity for C. trachomatis in human patients is
neither proof of active infection of the rectum, nor of coloniza-
tion of the intestine. In this study, we were interested to assess
whether chlamydiae can be detected in intestinal biopsy tissue
samples.
Amongst a group of case patients, with pathology records
indicating a documented or suspected chlamydial infection
(n = 32), Chlamydia species were identified in only 12.5%; three
patients were positive for C. trachomatis and one for C. abortus.
Most patients in the case group did not have a current C. tra-
chomatis infection detected by NAAT. They were identified using
the search term ‘chlamydia’ in the clinical history or in the
comments of the histopathology reports. It is probably rare that
Chlamydia-positive patients undergo a colonoscopy. In contrast
to the controls, the case group comprised a higher number of
younger patients (mean 38.8) in which inflammatory lesions
were diagnosed more frequently. The male C. trachomatis-
positive patient had proctitis caused by an LGV genotype, which
is known to result in colonoscopic investigation for suspected
inflammatory bowel disease (de Vries 2014). The most frequent
causes for infectious proctitis are STIs acquired through anal
intercourse and include the pathogens N. gonorrhoeae, C. tra-
chomatis (including LGV), herpes simplex virus and Treponema
pallidum (de Vries 2014). There are ongoing epidemics of LGV
amongst HIV-infected MSM in Switzerland (Kamarashev et al.
2010) and elsewhere in Europe (Ward et al. 2007; de Vrieze et al.
2013; Peuchant et al. 2016).
The two female C. trachomatis-positive patients had positive
results in appendix tissue, the only submitted tissue from these
patients. Spread of sexually transmitted C. trachomatis from the
endocervix to the fallopian tube and then to the appendix and
perihepatitis (Fitz-Hugh Curtis syndrome) are well-recognized
complications of ascending chlamydial infection in women. In
general, the number of appendix or cecum tissue specimens
(11/32 cases and 8/234 controls) was too low to draw any con-
clusions. The cecum had the highest chlamydial load in an ex-
perimental study in ducks (Thierry et al. 2016) andwas the target
tissue in themouse GI tract following oral C. muridarum infection
(Yeruva et al. 2013b). Moreover, the cecum remained positive for
up to 100 days post infection in the latter study (Yeruva et al.
2013b).
The finding of C. abortus by Arraymate microarray in the
colon of one female patient aged over 80 years is surprising.
Chlamydia abortus is an animal pathogen causing abortion,
stillbirth and neonatal losses in sheep and goats, and to a lesser
extent, in cattle, but is also known for its zoonotic potential
(Essig and Longbottom 2015). Pregnant women are at risk when
they come into contact with the pathogen but intestinal carriage
of C. abortus in humans has not been reported before. Data
anonymization for ethical reasons made it impossible to deter-
mine whether the patient had any history of contact with rumi-
nants. The patient suffered from colitis, but this finding seemed
unlikely to be associated with an intestinal C. abortus infection,
given that samples from follow-up investigations (n = 4) con-
tinuously revealed colitis while remaining Chlamydia-negative.
All Chlamydia-positive samples contained 23S rRNA gene
copy numbers ranging from 7.8 to 349.1 copies perμl, and, where
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present, revealed only single IHC-positive cells per section in the
lamina propria of the appendix or rectum. These findings are
indicative of a low-level infection, which would fit with the col-
onization hypothesis (Bavoil et al. 2017), or might be the result
of contamination. Asymptomatic intestinal infection after ex-
perimental oral C. psittaci inoculation in ducks also resulted in
the detection of few chlamydial inclusions by IHC (Thierry et al.
2016). Comparable to our findings, single chlamydial inclusions
were present in the epitheliumof the avian cecumand its subep-
ithelial tissue in the absence of histopathological lesions. In this
avian study, chlamydial load measured by PCR was highest in
the cecum which contrasted with the detection of very few in-
clusions by IHC. Sensitivity of IHC is much lower than PCR as
only inclusions can be detected by IHC rather than individual
elementary and reticulate bodies or DNA copies. Direct compari-
son between IHC and PCRmight be difficult if sections have been
taken from different levels of the FFPE blocks, although we tried
to reduce this limitation in our study by taking alternating con-
secutive sections for each method. Moreover, PCR on retrospec-
tive FFPE material can be critical as preparation and storage of
FFPE blocks leads to physical and chemical changes of DNA of
the tissue reducing the length of amplifiable PCR fragments (Bu-
rach et al. 2014). We tried to overcome this drawback by choosing
PCR methods targeting DNA fragments smaller than 200 base
pairs, and in case of a positive result, investigating serial sec-
tions of FFPE tissue. However, the limited length of the ampli-
fied 23S rRNA gene fragments will not allow comparative studies
and phylogenetic analysis with corresponding C. trachomatis se-
quences on this material. Amplification of a VD-I region of ompA
was only successful in two positive patients revealing homology
to the LGV L2 ompA-genotype in themale and to ompA-genotype
F in one female patient.
In the past, chlamydial infections have been linked to neo-
plastic diseases such as ocular MALT lymphoma (Ponzoni and
Ferreri 2017). Moreover, chlamydial infections in animal hosts
such as the pig can induce enteritis and diarrhea (Schautteet and
Vanrompay 2011). Simkania negevensis infection rate in colonic
biopsies was significantly higher in patients with Crohn’s dis-
ease and ulcerative colitis compared to control patients under-
going colonoscopy suggesting that thisChlamydia-like bacterium
might be involved in the inflammatory processes of chronic
bowel diseases (Belluzzi et al. 2017). The association of chlamy-
dial infections and neoplastic or intestinal inflammatory pro-
cesses prompted us to screen intestinal biopsy samples from
randomly selected patients subjected to colonoscopy. In the con-
trol group (n = 234), we were not able to detect chlamydial DNA
in 464 FFPE blocks containing ileum, colon, cecum, appendix or
rectum. This could be explained in part by the limitations of
this study. The control group were older patients undergoing
colonoscopy and was therefore biased towards hyperplastic and
neoplastic lesions, rather than younger adults who are at higher
risk of sexually transmittedC. trachomatis infection. Also, inflam-
matory processes in the control group were less common. Due
to these limitations, we think it would be premature to conclude
that C. trachomatis in not present in the GI tract of patients with-
out history of chlamydial infection. A larger sample size target-
ing the younger and sexually active population would be worth
investigating in future studies.
Finally, we have to consider that the presence of C. trachoma-
tis DNA/antigen in anorectal swabs or intestinal biopsy samples
does not prove that a sustained infection with living/replicating
bacteria has occurred. Such findings might represent a mere
contamination with non-viable organisms, as NAATs cannot de-
termine whether the organism is viable. Isolation studies or the
use of other viability assays are impossible for FFPE material.
Prospective studies on fresh tissue samples from the GI tract
and with concurrent specimens from genitourinary, anorectal
and oropharyngeal sites are required to confirm the findings ob-
tained in this study.
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